These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 11913973)
1. A novel in vitro assay for deubiquitination of I kappa B alpha. Strayhorn WD; Wadzinski BE Arch Biochem Biophys; 2002 Apr; 400(1):76-84. PubMed ID: 11913973 [TBL] [Abstract][Full Text] [Related]
2. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway. Alkalay I; Yaron A; Hatzubai A; Orian A; Ciechanover A; Ben-Neriah Y Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10599-603. PubMed ID: 7479848 [TBL] [Abstract][Full Text] [Related]
3. Inactivation of NF-kappa B inhibitor I kappa B alpha: ubiquitin-dependent proteolysis and its degradation product. Li CC; Dai RM; Longo DL Biochem Biophys Res Commun; 1995 Oct; 215(1):292-301. PubMed ID: 7575604 [TBL] [Abstract][Full Text] [Related]
4. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Chen Z; Hagler J; Palombella VJ; Melandri F; Scherer D; Ballard D; Maniatis T Genes Dev; 1995 Jul; 9(13):1586-97. PubMed ID: 7628694 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide. Gao Y; Lecker S; Post MJ; Hietaranta AJ; Li J; Volk R; Li M; Sato K; Saluja AK; Steer ML; Goldberg AL; Simons M J Clin Invest; 2000 Aug; 106(3):439-48. PubMed ID: 10930447 [TBL] [Abstract][Full Text] [Related]
6. Kinetic and mechanistic studies on the hydrolysis of ubiquitin C-terminal 7-amido-4-methylcoumarin by deubiquitinating enzymes. Dang LC; Melandri FD; Stein RL Biochemistry; 1998 Feb; 37(7):1868-79. PubMed ID: 9485312 [TBL] [Abstract][Full Text] [Related]
7. HSP27 is a ubiquitin-binding protein involved in I-kappaBalpha proteasomal degradation. Parcellier A; Schmitt E; Gurbuxani S; Seigneurin-Berny D; Pance A; Chantôme A; Plenchette S; Khochbin S; Solary E; Garrido C Mol Cell Biol; 2003 Aug; 23(16):5790-802. PubMed ID: 12897149 [TBL] [Abstract][Full Text] [Related]
8. Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome. Wilkinson KD Semin Cell Dev Biol; 2000 Jun; 11(3):141-8. PubMed ID: 10906270 [TBL] [Abstract][Full Text] [Related]
9. Appearance of apparently ubiquitin-conjugated I kappa B-alpha during its phosphorylation-induced degradation in intact cells. Traenckner EB; Baeuerle PA J Cell Sci Suppl; 1995; 19():79-84. PubMed ID: 8655651 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase. Yaron A; Gonen H; Alkalay I; Hatzubai A; Jung S; Beyth S; Mercurio F; Manning AM; Ciechanover A; Ben-Neriah Y EMBO J; 1997 Nov; 16(21):6486-94. PubMed ID: 9351830 [TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation. Han Y; Weinman S; Boldogh I; Walker RK; Brasier AR J Biol Chem; 1999 Jan; 274(2):787-94. PubMed ID: 9873017 [TBL] [Abstract][Full Text] [Related]
12. Control of IkappaBalpha proteolysis by the ubiquitin-proteasome pathway. Tanaka K; Kawakami T; Tateishi K; Yashiroda H; Chiba T Biochimie; 2001; 83(3-4):351-6. PubMed ID: 11295496 [TBL] [Abstract][Full Text] [Related]
13. Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo. Rodriguez MS; Wright J; Thompson J; Thomas D; Baleux F; Virelizier JL; Hay RT; Arenzana-Seisdedos F Oncogene; 1996 Jun; 12(11):2425-35. PubMed ID: 8649784 [TBL] [Abstract][Full Text] [Related]
14. Proteasome regulation of Fas ligand cytotoxicity. Matsui K; Omura S; Cui H; Schauer SL; Sonenshein GE; Ju ST Eur J Immunol; 1997 Sep; 27(9):2269-78. PubMed ID: 9341769 [TBL] [Abstract][Full Text] [Related]
15. SCF(beta-TRCP) and phosphorylation dependent ubiquitinationof I kappa B alpha catalyzed by Ubc3 and Ubc4. Strack P; Caligiuri M; Pelletier M; Boisclair M; Theodoras A; Beer-Romero P; Glass S; Parsons T; Copeland RA; Auger KR; Benfield P; Brizuela L; Rolfe M Oncogene; 2000 Jul; 19(31):3529-36. PubMed ID: 10918611 [TBL] [Abstract][Full Text] [Related]
16. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Palombella VJ; Rando OJ; Goldberg AL; Maniatis T Cell; 1994 Sep; 78(5):773-85. PubMed ID: 8087845 [TBL] [Abstract][Full Text] [Related]
17. Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo. Krappmann D; Wulczyn FG; Scheidereit C EMBO J; 1996 Dec; 15(23):6716-26. PubMed ID: 8978697 [TBL] [Abstract][Full Text] [Related]
18. Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required. Van Antwerp DJ; Verma IM Mol Cell Biol; 1996 Nov; 16(11):6037-45. PubMed ID: 8887633 [TBL] [Abstract][Full Text] [Related]
19. The carboxy-terminus of I kappaB alpha determines susceptibility to degradation by the catalytic core of the proteasome. Kroll M; Conconi M; Desterro MJ; Marin A; Thomas D; Friguet B; Hay RT; Virelizier JL; Arenzana-Seisdedos F; Rodriguez MS Oncogene; 1997 Oct; 15(15):1841-50. PubMed ID: 9362451 [TBL] [Abstract][Full Text] [Related]
20. Regulatory functions of ubiquitination in the immune system. Ben-Neriah Y Nat Immunol; 2002 Jan; 3(1):20-6. PubMed ID: 11753406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]